NHS Psoriasis Management with single and multiple biologic therapies
Research type
Research Study
Full title
The effectiveness of NHS Psoriasis Management with single and multiple biologic Therapies in UK clinical practice
IRAS ID
133684
Contact name
Anthony Bewley
Contact email
Sponsor organisation
Novartis Pharmaceuticals UK Ltd
Research summary
The aim of this study is to describe the patterns of first and subsequent biologic therapy use during normal clinical care in the UK NHS and the characteristics of patients who have and have not received a second, third or fourth biologic.
The results of this study will contribute to the evidence base on the use of second and subsequent biologics in patients with psoriasis which will be useful in the future to clinicians and patients making decisions about treatment options following a first biologic.
The study will be an observational multi-centre descriptive study with retrospective review of medical records. It will be conducted at 8 to 12 NHS Hospital Dermatology clinics, collecting data from 200-250 patients, approximately 25 from each centre.REC name
London - Brent Research Ethics Committee
REC reference
13/LO/1008
Date of REC Opinion
18 Jun 2013
REC opinion
Favourable Opinion